J. W. Kerr Grieve

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

Isla S. Mackenzie, Ian Ford, George Nuki et al. · The Lancet · 2020 · 342 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +10

Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial

Isla S. Mackenzie, Amy Rogers, Neil R Poulter et al. · The Lancet · 2022 · 216 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +10

Cost per fall: a potentially misleading indicator of burden of disease in health and residential care settings

Terry Haines, Jenny Nitz, J. W. Kerr Grieve et al. · Journal of Evaluation in Clinical Practice · 2011 · 27 citations · Full text

Public Affairs, Community Health, Cost-effectiveness Analysis +9

Cost of falls amongst aged care facility residents in Australia

Terry Haines, Jenny Nitz, J. W. Kerr Grieve et al. · Journal of Evaluation in Clinical Practice · 2012 · 19 citations

Medicine, Geriatric Medicine, Gerontological Nursing +11

Factors influencing home blood pressure monitor ownership in a large clinical trial

Thineskrishna Anbarasan, Amy Rogers, David Rorie et al. · Journal of Human Hypertension · 2021 · 12 citations · Full text

Medicine, Cardiology, Preventive Medicine +16